Sara M. Tolaney, MD, MPH, Dana-Farber Cancer Institute, Harvard University

Expert Perspectives On Advanced Hormone Receptor-Positive Breast Cancer

January 29th 2021

Breast oncologists review the impact of recent clinical trial data on treatment decisions for patients with HR-positive early-stage and metastatic breast cancer.

Triple-Negative Breast Cancer: Expert Perspectives On Recent Advances

October 23rd 2020